Ina Haendle

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

Beatrice Thurner, Ina Haendle, Claudia Röder et al. · The Journal of Experimental Medicine · 1999 · 1.2K citations · Full text

Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells

Beatrice Schuler-Thurner, Detlef Dieckmann, Petra Keikavoussi et al. · The Journal of Immunology · 2000 · 202 citations · Full text

A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use

Bernadette Feuerstein, Thomas Berger, Christian Maczek et al. · Journal of Immunological Methods · 2000 · 159 citations

Cryopreserved Aliquots, Immunology, Antigen Processing +6

Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab

Michael Hertl, Ina Haendle, Gerold Schuler et al. · British Journal of Dermatology · 2005 · 84 citations

Inflammation, Rheumatology, Autoimmune Disease +15

Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients

Michael Erdmann, Ina Haendle, Steve Voland et al. · JCI Insight · 2017 · 83 citations · Full text